Tower Research Capital LLC (Trc) Gilead Sciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 38,411 shares of GILD stock, worth $3.61 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
38,411
Previous 122,790
68.72%
Holding current value
$3.61 Million
Previous $8.42 Million
61.79%
% of portfolio
0.09%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.8 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.19 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.81 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.65 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $118B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...